{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on the Impact of Cardiovascular Drugs on Myocardial Injury After Noncardiac Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomised controlled trial was conducted across multiple international centers"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were adults undergoing noncardiac surgery, identified by elevated cTn levels within 30 days post-surgery"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either a regimen of cardiovascular drugs (aspirin, antihypertensives, statins) or standard care"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the efficacy of cardiovascular drugs in reducing mortality related to myocardial injury after noncardiac surgery (MINS)"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the reduction in postoperative mortality within 30 days"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealment achieved through sealed envelopes"
      },
      "Blinding": {
        "score": 1,
        "evidence": "Outcome assessors were blinded to group assignments"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention group and 100 to the control group, recruited between January 2020 and June 2021"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis included 98 participants in the intervention group and 97 in the control group, following an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "showing a significant effect size (hazard ratio = 0.75, 95% CI 0.60 to 0.90; p = 0.01)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild, with 3% of the intervention group and 1% of the control group experiencing mild gastrointestinal side-effects"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678"
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by the National Institutes of Health"
      }
    },
    "total_score": 23,
    "max_score": 25
  },
  "model": "gpt-4o"
}